Gaumard Scientific Co, Inc.

Gaumard Scientific Co, Inc. (Gaumard Scientific Company, Inc. Division), a woman-owned small business based in Miami, Florida, manufactures and sells high-fidelity medical simulation equipment to the federal government as a prime contractor, competing predominantly on full-and-open procurements without set-aside restrictions despite its woman-owned designation.

Gaumard's concrete capability portfolio centers on advanced patient simulators, training mannequins, childbirth trainers, trauma simulation devices, and associated consumables and accessories. The company manufactures all products domestically at its Miami facility and serves healthcare education, emergency response training, and military medical readiness across federal agencies. Representative contracts include a $15 million single-award indefinite-delivery contract from the Defense Logistics Agency Medical Supply Chain (awarded March 2026, running through March 2031) for advanced medical simulation technologies; a $204.6 thousand purchase order from Veterans Integrated Service Network 16 for patient simulators (September 2026); a $119.4 thousand total-small-business set-aside purchase order from Pacific Air Forces for clinical response whole-body simulators (December 2025); and a $106.3 thousand delivery order from DLA Medical Supply Chain for HAL Advanced Multipurpose Patient Simulator equipment (April 2026). Gaumard also holds a General Services Administration Multiple Award Schedule contract (47QSEA21D002V) valued at $400,000 through February 2026, which serves as a streamlined procurement vehicle for federal agencies acquiring its simulation portfolio.

Gaumard's customer concentration is extreme and represents a structural recompete risk. The Defense Logistics Agency Troop Support Medical accounts for 1,112 awards (84% of the award count) and $88.1 million (87% of combined potential value) — a 20-to-1 concentration ratio that dwarfs all other customers. The Department of the Navy Bureau of Medicine and Surgery ranks second with only 33 awards ($674 thousand), followed by the Department of the Army Medical Command (25 awards, $1.9 million), Defense Health Agency (18 awards, $784 thousand), and the Department of the Air Force (17 awards, $1.3 million). This portfolio is almost entirely captured by a single customer segment: DLA Medical Supply Chain.

Gaumard's work flows through two dominant parent vehicles. The Indefinite Delivery Contract SPE2DH20D0042 carries 686 task orders worth $10.8 million in combined potential value, while the DLA Medical Capital Equipment Program accounts for 397 task orders worth $8.2 million. A newer indefinite-delivery vehicle, SPE2DH26D0009 (awarded March 2026), holds 25 task orders valued at $511 thousand. The GSA Multiple Award Schedule contributes 12 task orders ($1.6 million), and one minor IDC (DLA12087C4943) carries a single task order. Together, these vehicles represent the totality of Gaumard's prime posture — no subcontract footprint appears in the source data.

Activity trajectory shows recent deceleration. Annual award counts were 131 (2022), 206 (2023), 148 (2024), 59 (2025), and 35 through September 2026, reflecting a sharp drop in the past eighteen months. Eleven awards totaling $661 thousand in potential value reach ultimate completion within the next twenty-four months, indicating modest recompete exposure over that window but masking the larger structural challenge: Gaumard's entire federal presence depends on continued task-order activity through two DLA indefinite-delivery vehicles. The company has served forty-nine distinct customer agencies since 1982 but derives 91% of award count and combined potential value from five agencies, with DLA alone accounting for 87% of dollars. Category concentration is correspondingly narrow: 1,115 of 1,322 awards (84%) fall under NAICS 424210 (Medical, Dental, and Hospital Equipment Merchant Wholesalers), and 1,105 awards (84%) carry PSC code for hospital furniture and equipment supplies. Gaumard competes full-and-open despite its woman-owned status; only five awards in the visible portfolio carry set-aside designations (four total-small-business, one competitive 8(a)), suggesting the company does not rely on set-aside vehicles for its prime footprint.